Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intramuscular versus intranasal naloxone for reversal of fentanyl-induced opioid toxicity
NL-OMON59895Phase 2Completed
- Sponsor
- Leiden University Medical Center
- Start
- Sep 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of naloxone in opioid intoxication (2 arms), sponsored by Leiden University Medical Center. Primary endpoint: Number of naloxone administrations. Started Sep 2023; status: completed.
02
Drugs
naloxone
03
Conditions
opioid intoxication
Beyond the preview
Go deeper on NL-OMON59895.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON59895.